Anti-VCAM1 antibody [EPR5047],Abcam,AB134047

Anti-VCAM1 antibody [EPR5047] (ab134047) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), I-ELISA, ICC/IF, IHC-P, IP and WB. Anti-VCAM1 antibody [EPR5047] (ab134047) was first used in a scientific publication in 2013 and has been cited over 309 times in peer reviewed journals. It's performance in Western Blot and IHC in mouse and human samples is trusted by the scientific community. Abcam's high quality manufacturing and validation processes ensure Anti-VCAM1 antibody [EPR5047] (ab134047) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. The specificity of Anti-VCAM1 antibody [EPR5047] (ab134047) has been confirmed by Western Blot testing in VCAM1 knockout A549 cells ( ab273758 ). Anti-VCAM1 antibody [EPR5047] (ab134047) has 16 independent reviews from customers. Anti-VCAM1 antibody [EPR5047] (ab134047) specifically detects VCAM1 (UniProt ID: P29533; Molecular weight: 79kDa) and is sold in 100 µL and 1 mL selling sizes. Conjugation-ready, carrier free format available for antibody clone EPR5047 - ab215380 . Antibody clone EPR5047 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor ® 647, HRP, PE, FITC, APC ( ab194319 , ab195540 , ab223981 , ab223982 , ab223983 ). - Specificity confirmed with SYP knockout cell line validation Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .